Page last updated: 2024-11-12
pd 168368
Description
PD 168368: a neuromedin B receptor antagonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 9937534 |
CHEMBL ID | 329650 |
SCHEMBL ID | 6249801 |
MeSH ID | M0378152 |
Synonyms (19)
Synonym |
CHEMBL329650 , |
(2s)-3-(1h-indol-3-yl)-2-methyl-2-[(4-nitrophenyl)carbamoylamino]-n-[(1-pyridin-2-ylcyclohexyl)methyl]propanamide |
pd 168368 |
pd-168368 |
pd168368 , |
gtpl621 |
(s)-3-(1h-indol-3-yl)-2-methyl-2-[3-(4-nitro-phenyl)-ureido]-n-(1-pyridin-2-yl-cyclohexylmethyl)-propionamide |
bdbm50071735 |
(s)-a-methyl-a-[[[(4-nitrophenyl)amino]carbonyl]amino]-n-[[1-(2-pyridinyl)cyclohexyl]methyl]-1h-indole-3-propanamide |
SCHEMBL6249801 |
204066-82-0 |
J-013285 |
(s)-3-(1h-indol-3-yl)-2-methyl-2-(3-(4-nitrophenyl)ureido)-n-((1-(pyridin-2-yl)cyclohexyl)methyl)propanamide |
Q27088274 |
pd 168368 is known as an nmbr antagonist. |
MS-30117 |
HY-116216 |
CS-0064383 |
AKOS040759496 |
Research Excerpts
Dosage Studied
Protein Targets (2)
Inhibition Measurements
Biological Processes (17)
Molecular Functions (4)
Ceullar Components (2)
Bioassays (6)
Assay ID | Title | Year | Journal | Article |
AID42490 | Antagonism of recombinant human bombesin receptor (bb1) labeled with [125I]- [Tyr] bombesin stably expressed in CHO cells | 1998 | Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
| PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. |
AID42630 | In vitro binding affinity at Bombesin BB2 receptor in the presence of [125I]-[Tyr] bombesin. | 1998 | Bioorganic & medicinal chemistry letters, Sep-22, Volume: 8, Issue:18
| PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. |
AID1346439 | Human BB1 receptor (Bombesin receptors) | 2009 | Peptides, Aug, Volume: 30, Issue:8
| Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. |
AID1346539 | Human BB2 receptor (Bombesin receptors) | 2009 | Peptides, Aug, Volume: 30, Issue:8
| Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. |
AID1346497 | Rat BB1 receptor (Bombesin receptors) | 1999 | The Journal of pharmacology and experimental therapeutics, Sep, Volume: 290, Issue:3
| Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. |
AID1346539 | Human BB2 receptor (Bombesin receptors) | 1999 | The Journal of pharmacology and experimental therapeutics, Sep, Volume: 290, Issue:3
| Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.01 (24.57) | Research Supply Index | 2.77 (2.92) | Research Growth Index | 4.78 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |